Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Central European Cooperative Oncology Group (CECOG) is a prominent academic research organization (ARO) founded in 1999 to advance cancer research and treatment standards across Central and Southeastern Europe. Headquartered in Vienna, Austria, the organization coordinates a network of over 150 oncology centers in more than 20 countries, facilitating large-scale clinical trials. CECOG specializes in the design and management of Phase II through Phase IV clinical studies, often collaborating with the pharmaceutical industry to evaluate innovative therapies. Beyond clinical trials, the group is widely recognized for its educational programs and the development of regional consensus guidelines for oncology practice. By bridging the gap between academic research and clinical application, CECOG plays a vital role in integrating the Central European medical community into the global oncology landscape.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Central European Cooperative Oncology Group.